Please provide your email address to receive an email when new articles are posted on . A guide published in JAMA Internal Medicine provides strategies to promote sleep and reduce sedative-hypnotic ...

THE questions of when to use, which to use and what may be accomplished from sedative-hypnotic drugs are, at times, very perplexing. The recent introduction into therapy of several new groups of these ...

Sedative-, hypnotic-, or anxiolytic- (SHA-) related disorders include SHA intoxication, SHA withdrawal, and SHA-use disorder. These disorders result from abuse of a class of medications known as ...

The prevalence of diagnosed disorders from recurrent use of sedative, hypnotic and antianxiety medications in adolescents and young adults has increased sharply since 2001, according to Rutgers Health ...

Fospropofol disodium injection, an intravenous sedative-hypnotic agent for sedation in adults undergoing diagnostic or therapeutic procedures, is closer to an FDA OK after the agency’s Advisory ...

June 4, 2009 — Sedatives and hypnotics may increase the risk for suicide in elderly patients, according to the results of a case-control study reported online in the June issue of BMC Geriatrics.

By Priyanjana Pramanik, MSc. A randomized JAMA trial shows that simple, behaviorally designed electronic health record ...

AMONG the nonbarbiturate sedative drugs that have recently been introduced has been 3,3-diethyl-2,4-dioxotetrahydropyridine (pyrithyldione), which has been marketed under the trade name of Presidon.